HI-SENSITIVE TSH

The HI-SENSITIVE TSH test measures Thyroid-Stimulating Hormone (TSH) in the blood using an assay capable of accurately detecting very low concentrations. TSH is produced by the pituitary gland, a small gland located at the base of the brain. It regulates the thyroid gland and instructs it to produce the thyroid hormones thyroxine (T4) and triiodothyronine (T3).

The pituitary and thyroid glands work through a feedback system. When thyroid-hormone levels are low, the pituitary generally releases more TSH to stimulate the thyroid. When thyroid-hormone levels are high, TSH production usually decreases. This relationship makes TSH a sensitive first-line marker for assessing thyroid function in many patients.

A high-sensitivity assay is especially useful for measuring suppressed or very low TSH concentrations, which may occur with hyperthyroidism or excessive thyroid-hormone treatment. The test may support screening for primary thyroid dysfunction and monitoring of patients receiving treatment for hypothyroidism or hyperthyroidism.

TSH alone cannot identify the exact cause of an abnormal result or assess every form of thyroid disease. Doctors frequently interpret it with free T4 and, when appropriate, free or total T3, thyroid antibodies, clinical symptoms and medical history.

Benefits of the Test

• Measures TSH accurately, including very low concentrations.
• Supports screening for underactive and overactive thyroid function.
• Helps detect selected cases of subclinical thyroid dysfunction.
• Supports monitoring of thyroid-hormone replacement treatment.
• May help monitor response following treatment for hyperthyroidism.
• Provides useful information for evaluating menstrual or fertility concerns related to thyroid function.
• Can support thyroid assessment during pregnancy when medically advised.
• Helps doctors decide whether free T4, T3 or thyroid-antibody testing is required.
• Requires only a routine venous blood sample.

Why Doctors Recommend This Test

A doctor may recommend HI-SENSITIVE TSH when symptoms suggest hypothyroidism, or underactive thyroid function. Possible symptoms include persistent tiredness, unexplained weight gain, sensitivity to cold, constipation, dry skin, hair thinning, muscle or joint discomfort, low mood, slow heart rate and heavy or irregular menstrual periods.

The test may also be ordered when symptoms suggest hyperthyroidism, or overactive thyroid function. These symptoms may include unexplained weight loss, rapid or irregular heartbeat, nervousness, irritability, tremors, sweating, heat intolerance, frequent bowel movements, muscle weakness and difficulty sleeping.

TSH is commonly used to monitor patients taking levothyroxine or another thyroid-hormone medicine. The result helps the treating doctor determine whether the prescribed dose is maintaining thyroid function within the appropriate clinical target. Patients should not change their medicine dose based on one result without medical guidance.

After treatment for hyperthyroidism, TSH may be assessed with free T4 and T3 to monitor response. TSH can remain suppressed for some time even after thyroid-hormone levels improve, so treatment decisions may require the complete thyroid profile rather than TSH alone.

The test may be requested during evaluation of menstrual irregularity, difficulty conceiving or recurrent pregnancy-related concerns because thyroid dysfunction can influence reproductive health. However, a TSH result cannot independently establish the cause of infertility.

During pregnancy, thyroid physiology and the expected TSH range change, particularly during the first trimester. Patients with existing thyroid disease, symptoms, autoimmune risk or other clinical indications may require testing and closer monitoring using pregnancy- and trimester-appropriate targets.

TSH may also be included in the evaluation of an enlarged thyroid gland, thyroid nodules, abnormal cholesterol, unexplained changes in heart rhythm or a suspected pituitary condition. Imaging or additional laboratory tests may be required depending on the findings.

Preparation Before Test

A venous blood sample is collected from a vein in the arm. Fasting is generally not required solely for a HI-SENSITIVE TSH test. If other fasting investigations are ordered at the same time, follow the instructions provided by the doctor or Focus Diagnostics.

TSH can change during the day, and minor differences may occur according to the collection time. When monitoring treatment or comparing serial results, collecting samples at a similar time of day and under similar conditions may improve consistency.

Inform the doctor and laboratory about all prescribed medicines, non-prescription medicines, vitamins and supplements. Thyroid-hormone medicines, antithyroid medicines, amiodarone, lithium, glucocorticoids, dopamine-related medicines and several other treatments may influence thyroid function or TSH results.

Biotin supplements can interfere with certain thyroid immunoassays and may produce misleading TSH or thyroid-hormone results. Inform the laboratory about the dose and timing of biotin use. Do not stop biotin or another prescribed treatment unless instructed by the doctor or laboratory.

Patients taking levothyroxine should follow the treating doctor's instructions regarding whether the sample should be collected before or after the daily dose. Using consistent timing for repeat monitoring may make results easier to compare.

Tell the healthcare professional about pregnancy, recent childbirth, serious illness, hospitalisation, thyroid surgery, radioactive iodine treatment, pituitary disease and any previous abnormal thyroid results. Acute illness and pregnancy can change the interpretation of TSH.

Normal Reporting Time

The HI-SENSITIVE TSH test is generally reported on the same day or within 24 hours after the laboratory receives an acceptable blood sample. It is commonly processed using an automated high-sensitivity immunoassay analyser.

Turnaround time may vary according to collection time, laboratory workload, analyser availability, quality-control procedures and the need to repeat or verify an unexpected result.

If TSH is abnormal, free T4, T3 or thyroid-antibody tests may need to be performed separately. The clinical conclusion may therefore take longer than the release of the individual TSH value.

Who Should Take This Test?

This test may be suitable for people with symptoms suggesting an underactive or overactive thyroid. It may also be recommended for people with a personal or family history of thyroid disease, autoimmune conditions, goitre or previous thyroid surgery.

Patients taking thyroid-hormone replacement commonly require regular TSH monitoring. Testing frequency depends on the treatment stage, dose changes, pregnancy status, age and other medical conditions. TSH is usually not checked immediately after every dose adjustment because the hormone system requires time to reach a new steady state.

Patients previously treated for hyperthyroidism may require TSH with free T4 or T3. The doctor determines the monitoring schedule according to the treatment and clinical response.

Pregnant women or women planning pregnancy with known thyroid disease, thyroid antibodies, symptoms or other risk factors may require testing. Pregnancy-specific interpretation is essential because general adult reference ranges may not be appropriate.

Women with irregular periods or fertility concerns may be advised to undergo thyroid assessment when clinically indicated. TSH is one part of the evaluation and does not replace other reproductive investigations.

Newborn screening for congenital hypothyroidism uses specialised age-specific protocols and reference ranges. A routine adult HI-SENSITIVE TSH test should not be interpreted as a substitute for an authorised newborn-screening programme.

Understanding the Result

High TSH: An increased TSH concentration commonly suggests that the thyroid is not producing enough hormone, particularly when free T4 is low. This pattern may occur with primary hypothyroidism. Hashimoto's thyroiditis is a common autoimmune cause, but thyroid surgery, radioactive iodine, certain medicines and other conditions may also be responsible.

A mildly elevated TSH with free T4 within its reference interval may be described as subclinical hypothyroidism. Treatment is not automatically required in every case. The decision depends on the TSH level, symptoms, age, pregnancy status, thyroid antibodies, cardiovascular risk and repeat results.

Low TSH: A decreased or suppressed TSH may suggest excess thyroid hormone, particularly when free T4 or T3 is elevated. Possible causes include Graves' disease, thyroid inflammation, autonomous thyroid nodules or excessive thyroid-hormone medicine.

Low TSH with free T4 and T3 within their reference intervals may be described as subclinical hyperthyroidism. The result may require confirmation and assessment of medicines, pregnancy, illness, age, heart risk and bone health.

Normal TSH: A result within the laboratory reference interval commonly suggests appropriate thyroid function in patients with an intact pituitary-thyroid feedback system. However, normal TSH does not exclude every thyroid or pituitary disorder, and further testing may be necessary when symptoms are strong.

Pituitary Conditions: TSH may be low, normal or sometimes mildly elevated in central thyroid dysfunction caused by a pituitary or hypothalamic disorder. Free T4 and clinical assessment are particularly important when a pituitary condition is suspected.

Detailed Information

The hypothalamus releases thyrotropin-releasing hormone, which stimulates the pituitary gland to produce TSH. TSH then acts on the thyroid gland, promoting the production and release of T4 and T3. These thyroid hormones influence energy use, body temperature, heart function, digestion, muscle function and development.

The feedback relationship is highly sensitive. A relatively small change in circulating free thyroid hormone may produce a larger change in TSH. High-sensitivity assays are designed to measure this response accurately across low concentrations and can assist in differentiating suppressed from low-normal results.

TSH reference intervals vary according to the assay, laboratory population, age, pregnancy stage and clinical context. Patients should use the range printed on their Focus Diagnostics report instead of comparing their value with another laboratory or an online chart.

Pregnancy requires special interpretation. TSH may be lower during the first trimester because pregnancy hormones stimulate the thyroid. Treatment targets for a pregnant patient with thyroid disease may differ from standard adult laboratory intervals.

Older adults may also show differences in TSH distribution. A result should not be labelled abnormal solely by comparison with a value from a different age group or laboratory. Symptoms, heart health, medicines and frailty may affect treatment decisions.

Acute or severe non-thyroid illness can temporarily change TSH and thyroid-hormone values. When results do not fit the clinical condition, repeat testing after recovery may be appropriate.

An abnormal TSH does not reveal the underlying cause. Further assessment may include free T4, free or total T3, anti-thyroid peroxidase antibodies, thyroglobulin antibodies, TSH-receptor antibodies, thyroid ultrasound or radioactive iodine uptake testing.

TSH should not be used alone to diagnose or monitor every thyroid condition. In central hypothyroidism, pregnancy, recent treatment for hyperthyroidism or certain serious illnesses, free thyroid hormones and specialist clinical assessment may be more important.

Patients should not begin, stop or adjust levothyroxine, antithyroid medication, iodine products or supplements based only on one TSH result. Treatment decisions require professional interpretation and, when necessary, confirmation with additional testing.